A detailed history of Dunhill Financial, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Dunhill Financial, LLC holds 37 shares of MRNA stock, worth $1,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37
Previous 32 15.63%
Holding current value
$1,860
Previous $3.36 Million 29.67%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$101.21 - $166.61 $506 - $833
5 Added 15.63%
37 $4.35 Million
Q1 2024

May 13, 2024

BUY
$85.37 - $115.44 $426 - $577
5 Added 18.52%
32 $3.36 Million
Q4 2023

Feb 12, 2024

BUY
$69.51 - $104.43 $1,876 - $2,819
27 New
27 $2.64 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $19.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.